RxDoctor Payments Data

James Blanks, OD

Optometrist · Tullahoma, TNNPI 1518952910

Payments from drug & device makers

$1,647in general payments, 2019–2025

Across 76 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$362
  • Oyster Point Pharma, Inc.$183
  • AbbVie$179
  • Bausch & Lomb Americas Inc.$176
  • Biotissue Holdings Inc.$135
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$111
  • plus $501 from 10 others

What the payments were for

  • Food & beverage$1,61198%
  • Education$362%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,647 in reported general payments places this provider in the 70th percentile of 1,122 optometrist providers in Tennessee.

See all optometrist providers in Tennessee

Medicare billing

Part B allowed, 2024
$207,515
Medicare patients
553
Services billed
3,084

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost105$40,262
RocklatanNetarsudil Mesylat/Latanoprost18$12,116
VyzultaLatanoprostene Bunod20$7,139
CombiganBrimonidine Tartrate/Timolol17$6,014
Travoprost27$4,402
Latanoprost315$3,496
Alphagan PBrimonidine Tartrate14$3,378
Loteprednol Etabonate20$2,764
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol16$2,060
Brimonidine Tartrate28$1,688
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat57$908
Timolol Maleate78$637
Doxycycline Hyclate20$557
Prednisolone Acetate19$488
Famciclovir11$34

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Combigan, Alphagan P$179$49,654136 claims
Aerie Pharmaceuticals, Inc.Rocklatan$77$12,11618 claims
Bausch & Lomb Americas Inc.Vyzulta$176$7,13920 claims
Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate$111$2,76420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,122 optometrist providers in Tennessee.

Other optometrist in Tullahoma

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →